Va Q Tec

Market position

The company positions itself as a pioneer in high-performance thermal energy efficiency and temperature-controlled supply chain solutions. EQT described it as a premium provider in this field and, at acquisition, set out plans to build a global player in high-performance thermal insulation and to combine va-Q-tec's pharma-focused business with portfolio company Envirotainer to form a one-stop-shop for mission-critical pharmaceutical transport.

The combination of vacuum insulation panels with phase change materials allows passive thermal packaging that maintains temperature for up to five days without external energy supply, and the same component technologies are applied across both packaging and stationary energy-efficiency markets. The company states it has operated climate-neutrally at all sites since 2021.

Technology

Core technologies are thin, high-performance vacuum insulation panels for thermal insulation and phase change materials that store and release thermal energy at defined temperatures. Combined into boxes and containers, they provide passive temperature control for up to five days without external energy input, and are also applied to improve the energy balance of buildings, hot water storage, heating pipelines and appliances.

Go-to-market

The company markets along defined business areas and applications — thermal packaging for eGrocery, bakery, retail, last-mile pharma and government/security, and thermal energy efficiency for construction, industry, household, commercial and laboratory appliances — selling components (VIPs, PCMs), complete box systems and thermal engineering services to business customers, supported by international subsidiaries.

Commercial and industrial customers in food and grocery delivery, bakery, retail, last-mile pharmaceutical logistics, government and security, construction, industrial technology, household, commercial and laboratory appliances, plus pharmaceutical and biotechnology companies running clinical trials.

Geography

Headquartered at Alfred-Nobel-Strasse 33, 97080 Würzburg, Germany, with a further German site in Kölleda, Thuringia, a UK subsidiary (va-Q-tec UK Ltd) and, as stated by the founder and CEO in 2023, ten subsidiaries worldwide. Reported 2024 sales were split between the rest of the European Union (EUR 49.53M), Germany (EUR 18.97M) and other regions (EUR 16.11M); North American sales of EUR 17.79M were reported for 2023.

History

va-Q-tec was founded by Dr. Joachim Kuhn, who has served as CEO since 2001, together with Dr. Roland Caps, founder and former Head of Research and Development. The company was listed with ISIN DE0006636681 and traded on Xetra under the ticker VQT and in London as 0RJD. In December 2022 it entered a Business Combination Agreement with Fahrenheit AcquiCo GmbH, a holding company controlled by the EQT X fund; the resulting takeover offer launched in January 2023 and passed its minimum acceptance threshold in February 2023, after which the bidder pursued a domination and profit and loss transfer agreement and a delisting. The company describes its own trajectory as moving from startup to global player.

Risks & controversies

Following the 2023 takeover the bidder pursued a domination and profit and loss transfer agreement and a delisting, reducing minority shareholder rights and public disclosure; both the Xetra and London listings are shown as inactive instruments. Reported segment sales declined from 2021 to 2023 before partially recovering in 2024, and ownership is highly concentrated, with EQT AB listed at 88.38 percent.